Zavain Dar - 08 Jul 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
08 Jul 2022
Net transactions value
$0
Form type
4
Filing time
12 Jul 2022, 17:01:27 UTC
Previous filing
16 Jun 2022
Next filing
28 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Other $0 +2,420 +13% $0.000000 20,565 08 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro data distribution from Lux Ventures IV, L.P. and its affiliates, in a transaction which is exempt pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.